serw-MX  [xml]  
 


    
 DeCS Categories

C04 Neoplasms .
C04.557 Neoplasms by Histologic Type .
C04.557.435 Neoplasms, Complex and Mixed .
C04.557.435.110 Adenomyoma .
C04.557.470 Neoplasms, Glandular and Epithelial .
C04.557.470.035 Adenoma .
C04.557.470.200 Carcinoma .
C04.557.470.200.025 Adenocarcinoma .
C04.588 Neoplasms by Site .
C04.588.322 Endocrine Gland Neoplasms .
C04.588.322.078 Adrenal Gland Neoplasms .
C04.588.322.078.265 Adrenal Cortex Neoplasms .
C04.588.322.078.265.500 Adrenocortical Adenoma .
C12 Male Urogenital Diseases .
C12.294 Genital Diseases, Male .
C12.294.565 Prostatic Diseases .
C12.294.565.500 Prostatic Hyperplasia .
C19 Endocrine System Diseases .
C19.053 Adrenal Gland Diseases .
C19.053.098 Adrenal Cortex Diseases .
C19.053.098.265 Adrenal Cortex Neoplasms .
C19.053.098.265.500 Adrenocortical Adenoma .
C19.053.347 Adrenal Gland Neoplasms .
C19.053.347.500 Adrenal Cortex Neoplasms .
C19.053.347.500.500 Adrenocortical Adenoma .
C19.344 Endocrine Gland Neoplasms .
C19.344.078 Adrenal Gland Neoplasms .
C19.344.078.265 Adrenal Cortex Neoplasms .
C19.344.078.265.500 Adrenocortical Adenoma .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Adenoma .
Adenomas .
Adenomas, Basal Cell .
Adenomas, Follicular .
Adenomas, Microcystic .
Adenomas, Monomorphic .
Adenomas, Papillary .
Adenomas, Trabecular .
Basal Cell Adenoma .
Basal Cell Adenomas .
Follicular Adenoma .
Follicular Adenomas .
Microcystic Adenoma .
Microcystic Adenomas .
Monomorphic Adenoma .
Monomorphic Adenomas .
Papillary Adenoma .
Papillary Adenomas .
Trabecular Adenoma .
Trabecular Adenomas .
Adenoma, Basal Cell .
Adenoma, Follicular .
Adenoma, Microcystic .
Adenoma, Monomorphic .
Adenoma, Papillary .
Adenoma, Trabecular .
A benign epithelial tumor with a glandular organization. .
1.00
80243735
 
Adenomyoma .
Adenomyomas .
A benign neoplasm of muscle (usually smooth muscle) with glandular elements. It occurs most frequently in the uterus and uterine ligaments. (Stedman, 25th ed) .
0.83
10406
 
Adrenocortical Adenoma .
Adenoma, Adrenocortical .
Conn Adenoma .
Conn Disease .
Adenoma, Conn .
Adenomas, Adrenal Cortical .
Adenomas, Adrenocortical .
Adenomas, Conn .
Adrenal Cortical Adenoma .
Adrenal Cortical Adenomas .
Adrenocortical Adenomas .
Conn Adenomas .
Conns Disease .
Disease, Conn .
Disease, Conn's .
Adenoma, Adrenal Cortical .
Conn's Disease .
A benign neoplasm of the ADRENAL CORTEX. It is characterized by a well-defined nodular lesion, usually less than 2.5 cm. Most adrenocortical adenomas are nonfunctional. The functional ones are yellow and contain LIPIDS. Depending on the cell type or cortical zone involved, they may produce ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE. .
0.80
401009
 
Adenocarcinoma .
Adenocarcinomas .
Adenocarcinomas, Basal Cell .
Adenocarcinomas, Granular Cell .
Adenocarcinomas, Oxyphilic .
Adenocarcinomas, Tubular .
Adenomas, Malignant .
Basal Cell Adenocarcinoma .
Basal Cell Adenocarcinomas .
Carcinomas, Cribriform .
Carcinomas, Granular Cell .
Carcinomas, Tubular .
Cribriform Carcinoma .
Cribriform Carcinomas .
Granular Cell Adenocarcinoma .
Granular Cell Adenocarcinomas .
Granular Cell Carcinoma .
Granular Cell Carcinomas .
Malignant Adenoma .
Malignant Adenomas .
Oxyphilic Adenocarcinoma .
Oxyphilic Adenocarcinomas .
Tubular Adenocarcinoma .
Tubular Adenocarcinomas .
Tubular Carcinoma .
Tubular Carcinomas .
Adenocarcinoma, Basal Cell .
Adenocarcinoma, Granular Cell .
Adenocarcinoma, Oxyphilic .
Adenocarcinoma, Tubular .
Carcinoma, Cribriform .
Carcinoma, Granular Cell .
Carcinoma, Tubular .
Adenoma, Malignant .
A malignant epithelial tumor with a glandular organization. .
0.75
2075138671
 
Prostatic Hyperplasia .
Adenomas, Prostatic .
Benign Prostatic Hypertrophy .
Hyperplasia, Prostatic .
Hypertrophy, Benign Prostatic .
Prostatic Adenomas .
Adenoma, Prostatic .
Benign Prostatic Hyperplasia .
Prostatic Hyperplasia, Benign .
Prostatic Hypertrophy, Benign .
Prostatic Adenoma .
Prostatic Hypertrophy .
Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. .
0.74
41819186